Bausch Health Companies | VRX - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Amgen USD 4.78B 1.12B 2026-03
ANI Pharmaceuticals USD 562.3M 344.37M 2026-03
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Bausch Health Companies USD 2.04B 42M 2026-03
Biogen USD 1.96B 69.6M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Canopy Growth CAD 98.72M 11.51M 2026-03
Corcept Therapeutics USD 214.5M 16.87M 2026-03
Danaher USD 52.95B 47.61B 2026-03
Drreddys Laboratories INR 74.33B 1.4B 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Novo Nordisk DKK 37.21B 9.56B 2026-03
Pacira USD 172.75M 20.93M 2026-03
Perrigo USD 935.6M 89.6M 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 206.12M 5.17M 2026-03
Supernus Pharmaceuticals USD 1.08B 879.06M 2026-03
Vertex Pharmaceuticals USD 1.85B 78.6M 2026-03
Zoetis USD 3.23B 1.68B 2026-03